Stock data
Vaxcyte, Inc. (PCVX)
Vaxcyte, Inc. (PCVX) reported net income of -US$766.63M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$923.67M | -US$766.63M | — |
| 2024 | — | — | -US$569.55M | -US$463.93M | — |
| 2023 | — | — | -US$468.04M | -US$402.27M | — |
| 2022 | — | — | -US$232.26M | -US$223.49M | — |
| 2021 | — | — | -US$103.67M | -US$100.08M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$284.30M | — |
| 2026-03-31 | — | -US$320.62M | — |
| 2025-12-31 | — | -US$246.51M | — |
| 2025-09-30 | — | -US$212.83M | — |
| 2025-06-30 | — | -US$166.57M | — |
| 2025-03-31 | — | -US$140.72M | — |
| 2024-12-31 | — | -US$137.08M | — |
| 2024-09-30 | — | -US$103.12M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.